Type 2 Diabetes Mellitus

• CLINICAL_TRIALS trial_result · 2023-11-21
  Clinical Trial Update: Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease [Phase 2, Phase 3]

  A Regeneron trial evaluated high-dose aflibercept for diabetic macular edema in diabetic eye disease. The Phase 2/3 study has completed, and…

• CLINICAL_TRIALS trial_result · 2023-11-21
  Clinical Trial Update: Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus [Phase 3]

  A Phase 3 clinical trial is evaluating the long-term safety and efficacy of DWP16001 in patients with type 2 diabetes mellitus; status is cu…

• CLINICAL_TRIALS trial_result · 2023-11-18
  Clinical Trial Update: Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus [Phase 2]

  Phase 2 trial update evaluating KD026 in combination with metformin for type 2 diabetes mellitus has been completed.

• CLINICAL_TRIALS trial_result · 2023-11-18
  Clinical Trial Update: A Comparison of SLx-4090 in Combination With Metformin Versus Metformin Therapy Alone in Patients With Type 2 Diabetes [Phase 2]

  Phase 2 trial comparing SLx-4090 plus metformin vs metformin alone in type 2 diabetes completed.

• CLINICAL_TRIALS trial_result · 2023-11-15
  Clinical Trial Update: Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes [Phase 4]

  Phase 4 clinical trial assessing efficacy and safety of EPA in patients with type 2 diabetes and hypertriglyceridemia.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2023-11-13
  Clinical Trial Update: Dexcom Continuous Glucose Monitoring in Long-term Care [NA]

  Clinical trial update for Dexcom continuous glucose monitoring in long-term care has completed; results posted in 2023.

• CLINICAL_TRIALS trial_result · 2023-11-13
  Clinical Trial Update: The Effect of Short-term Insulin Intensive Therapy Based on the Application of Insulin Pump and Real-time Dynamic Glucose Monitoring Technology on Reversing the Newly Diagnosed Type 2 Diabetes [Phase 4]

  Phase 4 clinical trial updating on the effect of short-term insulin intensive therapy guided by insulin pump and real-time continuous glucos…

• CLINICAL_TRIALS trial_result · 2023-11-09
  Clinical Trial Update: Almond Butter and Fasting Glucose [Phase 2]

  Phase 2 trial investigating almond butter's impact on fasting glucose in individuals with Type 2 Diabetes has completed with results posted.

• CLINICAL_TRIALS trial_result · 2023-11-09
  Clinical Trial Update: Effect of Moringa Leaf Capsules on Glycemic Control of Type 2 Diabetic Patients [Phase 2]

  A Phase 2 clinical trial evaluating the effect of Moringa leaf capsules on glycemic control in patients with type 2 diabetes.

• CLINICAL_TRIALS trial_result · 2023-11-07
  Clinical Trial Update: Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Aspirin in Type-2 Diabetic Patients With Subclinical Inflammation and High Cardiovascular Risk [Phase 3]

  Phase 3 trial comparing rivaroxaban to aspirin in high-risk type 2 diabetes patients with subclinical inflammation; results completed with r…

• CLINICAL_TRIALS trial_result · 2023-11-07
  Clinical Trial Update: Examination of Psychological Tools and Tracking in an Online Intervention for Type 2 Diabetes [NA]

  Completed clinical trial examining psychological tools and tracking in an online intervention for adults with Type 2 diabetes, with results …

• FDA approval · 2023-11-03
  FDA Approved: SITAGLIPTIN AND METFORMIN HYDROCHLORIDE — Original Application (Zydus Lifesciences Limited)

  FDA approved a fixed-dose combination of sitagliptin and metformin hydrochloride under an Original Application from Zydus Lifesciences Limit…

• CLINICAL_TRIALS trial_result · 2023-11-02
  Clinical Trial Update: A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin [Phase 3]

  Phase 3 study comparing tirzepatide to insulin lispro in Type 2 diabetes patients inadequately controlled on basal insulin, with or without …

• CLINICAL_TRIALS trial_result · 2023-11-02
  Clinical Trial Update: Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus. [Phase 3]

  Phase 3 trial update evaluating safety and effects of Biphasic Insulin Aspart 50 in patients with type 2 diabetes mellitus.

• CLINICAL_TRIALS trial_result · 2023-11-02
  Clinical Trial Update: Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes [Phase 3]

  Phase 3 trial comparing insulin detemir to insulin NPH in overweight/obese individuals with type 2 diabetes; results pertain to weight chang…

• CLINICAL_TRIALS trial_result · 2023-11-02
  Clinical Trial Update: eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk [Phase 2]

  Phase 2 pilot trial evaluating depression treatment to reduce diabetes risk has completed with results posted.

• CLINICAL_TRIALS trial_result · 2023-11-02
  Clinical Trial Update: Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes [Phase 3]

  Phase 3 trial comparing insulin aspart to glibenclamide in type 2 diabetes has been terminated.

• CLINICAL_TRIALS trial_result · 2023-11-02
  Clinical Trial Update: Intervention Mapping to Adapt a Mindfulness-based Intervention for Adults With Diabetes and Emotional Distress [NA]

  A completed clinical trial studied adapting a mindfulness-based intervention for adults with type 2 diabetes and emotional distress; results…

• CLINICAL_TRIALS trial_result · 2023-11-02
  Clinical Trial Update: INITIATE Plus (INITiation of Insulin to Reach A1c TargEt) Study [Phase 4]

  Phase 4 clinical trial update for INITIATE Plus studying initiation of insulin to reach A1c targets in type 2 diabetes, completed.

• CLINICAL_TRIALS trial_result · 2023-11-02
  Clinical Trial Update: Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs [Phase 4]

  Phase 4 trial update evaluating the efficacy of biphasic insulin aspart 30 in adults with type 2 diabetes not adequately controlled on oral …

• CLINICAL_TRIALS trial_result · 2023-11-02
  Clinical Trial Update: Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes [Phase 2]

  Phase 2 trial investigating the effect of liraglutide on weight and appetite in obese adults with type 2 diabetes.

• CLINICAL_TRIALS trial_result · 2023-11-02
  Clinical Trial Update: ACCESS: AI for pediatriC diabetiC Eye examS Study [NA]

  Clinical trial update for ACCESS: AI for pediatric diabetic eye exams completed with results posted.

• CLINICAL_TRIALS trial_result · 2023-11-02
  Clinical Trial Update: The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD [Phase 4]

  Phase 4 trial evaluating insulin detemir for blood glucose control in Taiwanese patients with Type 2 diabetes not controlled on oral antidia…

• FDA approval · 2023-10-30
  FDA Approved: SYNJARDY — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for Synjardy (empagliflozin and metformin hydrochloride) from Boehringer Ingelheim Pharmaceutica…

• FDA approval · 2023-10-30
  FDA Approved: TRIJARDY XR — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

  FDA approved a supplemental application for TRIJARDY XR (empagliflozin, linagliptin, metformin hydrochloride) from Boehringer Ingelheim Phar…